Davis Polk partner and IP & Commercial Transactions practice head Frank Azzopardi, partner David Bauer and counsel Samantha Lefland authored “Mitigating counterparty bankruptcy risk in ...
Davis Polk partners David Bauer and Matt Bacal, counsel Samantha Lefland and law clerk Ted Talas authored “Artificial intelligence in drug development” in the Legal 500: Life Sciences...
Webinar
1.0 CA - General; NY - Professional Practice / Practice Management
Davis Polk hosts a series of webinars focused on legal considerations for life sciences and healthcare companies. In this installment, senior lawyers discuss considerations and strategies...
Davis Polk partner David Bauer and counsel Samantha Lefland authored “Strategic considerations in life sciences partnering” in Financier Worldwide. In the article, the authors discuss...
Davis Polk partner and IP, Tech & Commercial Transactions head Frank Azzopardi and counsel Samantha Lefland and Chris Woller authored “Leveraging intellectual property and other intangi...
The recent rise of consumer and market interest in generative artificial intelligence (GAI) tools has spurred growing interest in GAI assets from strategic acquirers and private equity in...
Webinar
1.0 NY - Professional Practice / Practice Management
Davis Polk is pleased to host a series of webinars over the coming months focused on legal considerations for life sciences companies. In this first installment, senior members of the Dav...
